Anavex Receives FDA Meeting Approval for Rett Syndrome Phase 3 Trial

Filing content

Anavex announced that the FDA has granted its request for a meeting to discuss the inclusion of pediatric patients in its Phase 3 clinical trial for Rett syndrome.